Lipase@zeolitic imidazolate framework ZIF-90: A highly stable and recyclable biocatalyst for the synthesis of fruity banana flavour.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Jan 2021
Historique:
received: 07 06 2020
revised: 02 11 2020
accepted: 03 11 2020
pubmed: 9 11 2020
medline: 10 4 2021
entrez: 8 11 2020
Statut: ppublish

Résumé

A zeolitic imidazolate framework (ZIF-90) has been synthesized through solvothermal method. The structure was characterized by means of FT-IR spectroscopy, X-ray diffraction, thermogravimetric analysis (TGA), and scanning electron microscopy (SEM)/energy dispersive X-ray spectroscopy (EDS). The synthesized ZIF-90 was applied as a support for immobilization of porcine pancreatic lipase (PPL). The immobilized enzyme (PPL@ZIF-90) exhibited immobilization yield and efficiency of 66 ± 1.8% and 89 ± 1.4%, respectively. The pH and thermal stability of PPL was improved after immobilization and the initial activity was retained at about 57% after 20 days of storage at 4 °C for PPL@ZIF-90. Moreover, about 57% of the original activity was remained following 10 cycles of application. In Michaelis-Menten kinetic studies, K

Identifiants

pubmed: 33161085
pii: S0141-8130(20)34936-9
doi: 10.1016/j.ijbiomac.2020.11.011
pii:
doi:

Substances chimiques

Butyrates 0
Enzymes, Immobilized 0
Flavoring Agents 0
Imidazoles 0
Metal-Organic Frameworks 0
Lipase EC 3.1.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1301-1311

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Tohid Taghizadeh (T)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran 1417614411, Iran.

Atefeh Ameri (A)

Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Amin Talebian-Kiakalaieh (A)

Faculty of Petrochemicals, Iran Polymer and Petrochemical Institute, P.O. Box 14975-112, Tehran, Iran.

Somayeh Mojtabavi (S)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran 1417614411, Iran.

Alieh Ameri (A)

Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.

Hamid Forootanfar (H)

Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Sara Tarighi (S)

Faculty of Petrochemicals, Iran Polymer and Petrochemical Institute, P.O. Box 14975-112, Tehran, Iran. Electronic address: s.tarighi@ippi.ac.ir.

Mohammad Ali Faramarzi (MA)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran 1417614411, Iran. Electronic address: faramarz@tums.ac.ir.

Articles similaires

Humans Melanoma Skin Neoplasms Antineoplastic Combined Chemotherapy Protocols Randomized Controlled Trials as Topic
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase
Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
1.00
Carcinoma, Hepatocellular Liver Neoplasms Proto-Oncogene Proteins c-met Animals Humans

Classifications MeSH